Kirlappos H - Search Results

1

Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes.

Wagner E, Zatloukal K, Cotten M, Kirlappos H, Mechtler K, Curiel DT, Birnstiel ML. Wagner E, et al. Among authors: kirlappos h. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6099-103. doi: 10.1073/pnas.89.13.6099. Proc Natl Acad Sci U S A. 1992. PMID: 1631096 Free PMC article.

2

DNA-binding transferrin conjugates as functional gene-delivery agents: synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety.

Wagner E, Cotten M, Mechtler K, Kirlappos H, Birnstiel ML. Wagner E, et al. Among authors: kirlappos h. Bioconjug Chem. 1991 Jul-Aug;2(4):226-31. doi: 10.1021/bc00010a006. Bioconjug Chem. 1991. PMID: 1772904

3

Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels.

Cotten M, Längle-Rouault F, Kirlappos H, Wagner E, Mechtler K, Zenke M, Beug H, Birnstiel ML. Cotten M, et al. Among authors: kirlappos h. Proc Natl Acad Sci U S A. 1990 Jun;87(11):4033-7. doi: 10.1073/pnas.87.11.4033. Proc Natl Acad Sci U S A. 1990. PMID: 2349215 Free PMC article.

4

Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex.

Buschle M, Cotten M, Kirlappos H, Mechtler K, Schaffner G, Zauner W, Birnstiel ML, Wagner E. Buschle M, et al. Among authors: kirlappos h. Hum Gene Ther. 1995 Jun;6(6):753-61. doi: 10.1089/hum.1995.6.6-753. Hum Gene Ther. 1995. PMID: 7548275

5

Transloading of tumor antigen-derived peptides into antigen-presenting cells.

Buschle M, Schmidt W, Zauner W, Mechtler K, Trska B, Kirlappos H, Birnstiel ML. Buschle M, et al. Among authors: kirlappos h. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3256-61. doi: 10.1073/pnas.94.7.3256. Proc Natl Acad Sci U S A. 1997. PMID: 9096380 Free PMC article.

6

Transloading of tumor cells with foreign major histocompatibility complex class I peptide ligand: a novel general strategy for the generation of potent cancer vaccines.

Schmidt W, Steinlein P, Buschle M, Schweighoffer T, Herbst E, Mechtler K, Kirlappos H, Birnstiel ML. Schmidt W, et al. Among authors: kirlappos h. Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9759-63. doi: 10.1073/pnas.93.18.9759. Proc Natl Acad Sci U S A. 1996. PMID: 8790404 Free PMC article.

7

Cell-free tumor antigen peptide-based cancer vaccines.

Schmidt W, Buschle M, Zauner W, Kirlappos H, Mechtler K, Trska B, Birnstiel ML. Schmidt W, et al. Among authors: kirlappos h. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3262-7. doi: 10.1073/pnas.94.7.3262. Proc Natl Acad Sci U S A. 1997. PMID: 9096381 Free PMC article.

8

Vaccination with poly-L-arginine as immunostimulant for peptide vaccines: induction of potent and long-lasting T-cell responses against cancer antigens.

Mattner F, Fleitmann JK, Lingnau K, Schmidt W, Egyed A, Fritz J, Zauner W, Wittmann B, Gorny I, Berger M, Kirlappos H, Otava A, Birnstiel ML, Buschle M. Mattner F, et al. Among authors: kirlappos h. Cancer Res. 2002 Mar 1;62(5):1477-80. Cancer Res. 2002. PMID: 11888923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters